FUNDING & OPPORTUNITIES
The Milner Therapeutics Institute is part of the School of Biological Sciences and the School of Clinical Medicine at the University of Cambridge, and is dedicated to the conversion of ground breaking science into therapies. Based on the Cambridge Biomedical Campus, the institute is surrounded by a global therapeutic alliance of SMEs, pharma companies, academic institutions and venture capital firms.
We periodically run calls that offer physical space for startup companies, as well as opportunities for funding and collaboration. Please see below for a list of our current opportunities.
Our pharma partners in the Milner Therapeutics Consortium are working together with academics at the University, Babraham and Wellcome Sanger Institutes to better understand disease mechanisms and to discover and validate new therapeutic targets. These pre-clinical projects range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations and are expected to lead to joint publications with the company partners.
The 2023 call will be opening for applications soon. Visit the Consortium Call page for more information.
Fully funded Computational PhD Studentship - University of Cambridge and AstraZeneca
Developing molecular classifier and novel treatment approaches for childhood onset Inflammatory Bowel Diseases
Closing date: 31st January, 2023
Applications from prospective students are invited for a fully funded 3.5 year PhD studentship starting in October 2023, under the joint supervision of Dr Matthias Zilbauer (Cambridge Stem Cell Institute, University of Cambridge), Dr Namshik Han (Milner Therapeutics Institute, University of Cambridge), Dr Daniel Marks (Executive Medical Director, Early Clinical Immunology, AstraZeneca), Dr Daniele Corridoni and Dr. Tatiana Ort (Immunology Bioscience, AstraZeneca). This PhD program offers the unique opportunity to work at the interface of basic science and clinical medicine aiming to train independent, innovative scientists capable of delivering translational research using cutting edge computational methodologies.
We are looking for a highly motivated and enthusiastic individual capable of thinking and working independently. The ideal candidate has a strong background in, and exceptional enthusiasm for, computational biology and machine learning, as well as a strong interest in the underlying biological processes and disease mechanisms. Applicants should have or shortly expect to obtain a first or upper second-class degree from a UK university, or an equivalent standard from an overseas university, in a relevant subject such as applied mathematics, computer science, genetics or molecular biology.
These positions are open to UK citizens or overseas students who meet the UK residency requirements (home fees) or are able to augment the funds to cover the extra costs associated with international student fees. Full details of the University’s entrance requirements are specified on the following link: postgraduate.study.cam.ac.uk/application-process/entry-requirements.
For more information and to apply, visit: findaphd.com/phds/project/fully-funded-3-5-year-computational-phd-studentship-developing-molecular-classifier-and-novel-treatment-approaches-for-childhood-onset-inflammatory-bowel-diseases/?p150939
Are you a start-up interested in bio-incubator space?
We currently have a unique opportunity for you to be part of a vibrant Institute in a much sought after location on Cambridge Biomedical Campus. The Milner Therapeutics Institute has limited space for research intensive, R&D companies, working in an areas related to the Institute’s expertise (e.g. functional genomics, early target discovery, therapeutics). You will be working side by side with academics, entrepreneurs and industry scientists.
To discuss, please contact firstname.lastname@example.org